NCT02608567

Brief Summary

In patients with asymptomatic aortic stenosis (AS), the prognostic value of reduced left ventricular (LV) ejection fraction is well known. Consequently, there is class I indication for surgery in these patients when LV ejection fraction \<50%. However, there is growing evidences suggesting that subclinical LV dysfunction, and more particularly longitudinal myocardial dysfunction, may be a powerful early predictor of outcome, even when LV ejection is still preserved. In asymptomatic AS patients with LV ejection fraction \>50%, a reduced LV global longitudinal strain, as assessed using speckle tracking imaging with transthoracic echocardiography, may be an accurate marker to identify early subclinical LV dysfunction and thus, to improve the risk stratification, the management and the timing of surgery. Several mono-centric observational small studies recently reported results emphasizing the role of LV global longitudinal strain in AS patients. Therefore, a meta-analysis may be conducted and may provide meaningful data. The investigators hypothesized that LV global longitudinal strain is a determinant of outcome in asymptomatic patients with AS and preserved LV ejection fraction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 18, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

February 7, 2017

Status Verified

February 1, 2017

Enrollment Period

1.2 years

First QC Date

November 17, 2015

Last Update Submit

February 6, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Combined outcome of death and cardiovascular-related hospitalization (including aortic valve replacement)

    up to 10 years

Secondary Outcomes (1)

  • Combined outcome of death and cardiovascular-related hospitalization (without aortic valve replacement)

    up to 10 years

Study Arms (2)

Preserved LV GLS

Patients will be compared according to the level of LV global longitudinal strain (GLS) as derived from transthoracic echocardiography and speckle tracking analysis. Two groups will be compared regarding outcome: preserved LV GLS vs. reduced LV GLS. The definition use for reduced LV GLS will be \>-16%. An optimal threshold would also be calculated and derived from the pooled data.

Reduced LV GLS

The definition use for reduced LV GLS will be \>-16%. An optimal threshold would also be calculated and derived from the pooled data.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Asymptomatic patients with at least moderate aortic stenosis (mean pressure gradient \>25mmHg or aortic valve area \<1.5cm²) and left ventricular ejection fraction \>50%.

You may qualify if:

  • studies selected in PubMed, Embase, Ovid, and Google Scholar, published between 2005 and 2015 without language restriction according to the following criteria: "aortic stenosis" AND "longitudinal strain"

You may not qualify if:

  • Studies reporting global longitudinal strain derived from VVI and not speckle tracking analysis.
  • Studies with cohort of patients with aortic valve replacement indication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU LImoges

Limoges, 87000, France

Location

MeSH Terms

Conditions

Aortic Valve StenosisAsymptomatic Diseases

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow ObstructionDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Erwan Donal, MD, PhD

    European Association of Cardiovascular Imaging

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
EACVI board member - Research&Innovation committee member

Study Record Dates

First Submitted

November 17, 2015

First Posted

November 18, 2015

Study Start

October 1, 2015

Primary Completion

December 1, 2016

Study Completion

December 1, 2017

Last Updated

February 7, 2017

Record last verified: 2017-02

Locations